To deeper investigate the biological effects elicited by RIZ2 overexpression in colon cancer, 3D organoids were established, as they resume better the cancer tissues characteristics reproducing the complex in vivo architecture and represent a powerful tool for evaluating the efficacy of drug treatment. Here, PRDM2 is linked to malignant colon neoplasm.